On Monday, the FDA approved Truvada, the first medication intended to prevent HIV infections in people having sex with infected partners. In clinical trials where HIV-negative individuals had unprotected sex with multiple partners, including some with HIV, the pill reduced the risk of infection by 42 percent compared with a placebo. Another trial with heterosexual couples where one partner was infected found that Truvada, which is taken daily, reduced the risk by 75 percent. The FDA warned that the drug, which will cost patients about $450 a year, should be used in conjunction with other prevention methods.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- The real story behind Deliver Us From Evil
- 43 TV shows to watch in 2014
- How the South's ugly racial history is haunting ObamaCare
- If Democrats abandon immigration reform after Tuesday's likely loss, they will turn 2016 into a debacle
- What if Leo Strauss was right?
- Stop making fun of philosophy and read some philosophy
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- 6 things the happiest families all have in common
- Feast your eyes on this beautiful linguistic family tree
- How science can help you survive scary movies
Subscribe to the Week